Clinical Trials on Leukemia, Erythroblastic, Acute in Canada
Total 1149 results
-
PETHEMA FoundationCompleted
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, AcuteCanada, United States, United Kingdom, France, Italy
-
University Health Network, TorontoActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Relapsed Cancer | Refractory CancerCanada
-
PETHEMA FoundationCompletedAcute Promyelocytic LeukemiaSpain, Uruguay, Poland
-
CelgeneCompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Canada
-
PETHEMA FoundationCompletedAcute Promyelocytic LeukemiaSpain
-
Hoffmann-La RocheTerminatedLeukemia, Myeloid, AcuteItaly, Korea, Republic of, Belgium, Australia, United States, Canada, United Kingdom, Spain, Netherlands, France, Germany, New Zealand, Israel, Norway, Russian Federation, Switzerland, Austria, Finland, Panama
-
University Health Network, TorontoThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Hematologic Malignancy | Chronic Myelogenous Leukemia | Myelodysplasia | Hodgkin's DiseaseCanada
-
Therapeutic Advances in Childhood Leukemia ConsortiumGateway for Cancer ResearchCompletedLymphoblastic Leukemia, Acute, Childhood | Myelogenous Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
CelgeneRecruitingLeukemia, MyeloidUnited States, France, Canada
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, AcuteUnited States, Korea, Republic of, Australia, United Kingdom, Canada, France, Italy
-
Calithera Biosciences, IncTerminatedAcute Myelogenous LeukemiaUnited States, Canada
-
Hoffmann-La RocheCompletedLeukemia, Myeloid, AcuteUnited States, Canada, France, Italy
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States, Canada
-
Eisai Inc.TerminatedPediatric Acute Myelogenous Leukemia (AML)United States, Canada, Australia
-
University Health Network, TorontoTerminatedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | MyelodysplasiaCanada
-
Nova Scotia Health AuthorityTerry Fox Research InstituteCompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)Canada
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxActive, not recruitingLeukemia, Myeloid, AcuteCanada, United States, Poland, Switzerland, Germany
-
University Health Network, TorontoThe Hospital for Sick ChildrenRecruitingLeukemia, AcuteCanada
-
Gilead SciencesTerminatedAcute Myeloid LeukemiaUnited States, Canada, Germany
-
Vastra Gotaland RegionAustralasian Leukaemia and Lymphoma Group; The Canadian Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaFinland, Australia, Canada, New Zealand, Sweden, Estonia, Germany, Greece, Norway
-
University Health Network, TorontoCanadian Cancer Society (CCS)Completed
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteCanada, Norway, Belgium, Germany, Italy, Austria, France
-
University Health Network, TorontoNovartisCompletedChronic Phase Chronic Myeloid Leukemia | Philadelphia Positive Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blastic Phase Chronic Myeloid Leukemia | Resistant to Tyrosine Kinase Inhibitor TherapyCanada
-
Hebei Senlang Biotechnology Inc., Ltd.CompletedT-cell Acute Lymphoblastic Leukemia/LymphomaChina
-
PETHEMA FoundationNovartisCompleted
-
Kura Oncology, Inc.RecruitingAcute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Advanced Malignant Neoplasm | Mixed Phenotype Acute Leukemia | Mixed Lineage Leukemia | Mixed Lineage Acute LeukemiaUnited States, Spain, United Kingdom, France, Germany, Canada, Belgium, Italy
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States, Canada
-
Syndax PharmaceuticalsRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute LeukemiaUnited States, Israel, Spain, Australia, Netherlands, Germany, Canada, France, Italy, Lithuania
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS); Princess Margaret Hospital, University Health NetworkRecruitingAcute LeukemiaCanada
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
University Health Network, TorontoCelgeneTerminatedChronic Lymphocytic LeukaemiaCanada
-
PETHEMA FoundationCompleted
-
Clavis PharmaCompletedAcute Myeloid Leukemia (AML)United States, Spain, France, Ireland, United Kingdom, Australia, Belgium, Canada, Germany, Italy, Norway, Poland, Romania
-
CelgeneAbbVieActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Canada, France, United Kingdom, Belgium
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Fungal Infection | Neutropenia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Childhood Acute Myeloid Leukemia in Remission | Recurrent Childhood Acute Myeloid... and other conditionsUnited States, Canada, Puerto Rico
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Graft vs. Host Disease (GvHD)United States, Canada
-
Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia (AML)Canada, United States, Israel, Netherlands, Denmark, Spain, France, Italy, United Kingdom, Germany, Poland
-
Aegera TherapeuticsCompletedLeukemia, Myelomonocytic, AcuteUnited States, Canada
-
University of British ColumbiaAmgenTerminatedMinimal Residual Disease | B-cell Adult Acute Lymphoblastic Leukemia | Stem Cell LeukemiaCanada
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
National Cancer Institute (NCI)CompletedJuvenile Myelomonocytic Leukemia | Recurrent Disease | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Childhood Solid Neoplasm | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia... and other conditionsUnited States, Canada
-
PETHEMA FoundationDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Syntax for Science, S.LActive, not recruiting
-
Kronos BioTerminatedNucleophosmin 1-mutated Acute Myeloid LeukemiaIsrael, Spain, France, United States, Czechia, Hungary, Korea, Republic of, Germany, Italy, Poland, Brazil, Canada
-
Canadian Immunization Research NetworkCompleted
-
TakedaActive, not recruitingAcute Myeloid Leukemia (AML)United States, France, Italy, Poland, Canada
-
University Health Network, TorontoTerminated
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedAcute Lymphoblastic LeukemiaUnited States, Canada